True about Mycoplasma:
**Core Concept**
Mycoplasma are a type of bacteria that lack a cell wall, making them resistant to beta-lactam antibiotics like penicillin. This unique characteristic is due to the absence of peptidoglycan, a critical component of bacterial cell walls.
**Why the Correct Answer is Right**
The lack of a cell wall in Mycoplasma prevents the action of beta-lactam antibiotics, which target and inhibit the synthesis of peptidoglycan. As a result, Mycoplasma infections are often treated with antibiotics that target different cellular processes, such as macrolides (e.g., azithromycin) or tetracyclines (e.g., doxycycline). These antibiotics work by inhibiting protein synthesis or interacting with other molecular targets within the bacterial cell.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the unique characteristic of Mycoplasma that makes them resistant to beta-lactam antibiotics.
**Option B:** This option is incorrect as it does not provide a relevant statement about Mycoplasma.
**Option C:** This option is incorrect as it does not provide accurate information about Mycoplasma.
**Clinical Pearl / High-Yield Fact**
When treating Mycoplasma infections, it is essential to choose antibiotics that are effective against these unique bacteria. Macrolides and tetracyclines are often preferred due to their ability to target protein synthesis and other cellular processes.
**Correct Answer:** A.